Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men
OBJECTIVE--To determine the prevalence, incidence, and persistence of positivity for antibodies to hepatitis C virus (anti-HCV) and the potential for sexual transmission of the virus. DESIGN--A cohort analysis covering 1981-9 comparing estimated cumulative incidences of and seroconversion rates for...
Gespeichert in:
| Veröffentlicht in: | BMJ 1990-07, Vol.301 (6745), p.210-212 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 212 |
|---|---|
| container_issue | 6745 |
| container_start_page | 210 |
| container_title | BMJ |
| container_volume | 301 |
| creator | Melbye, M Biggar, R J Wantzin, P Krogsgaard, K Ebbesen, P Becker, N G |
| description | OBJECTIVE--To determine the prevalence, incidence, and persistence of positivity for antibodies to hepatitis C virus (anti-HCV) and the potential for sexual transmission of the virus. DESIGN--A cohort analysis covering 1981-9 comparing estimated cumulative incidences of and seroconversion rates for anti-HCV with those of hepatitis B core antibody (anti-HBc) and antibodies to the human immunodeficiency virus (anti-HIV). SETTING--Copenhagen and Aarhus, Denmark. SUBJECTS--259 Male members of a Danish homosexual organisation. MAIN OUTCOME MEASURES--Correlations of prevalence and incidence with a wide range of sexual lifestyle variables. RESULTS--Only four (1.6%) subjects were positive for anti-HCV in 1981. The estimated cumulative incidence of positivity for anti-HCV was 4.1% in 1984 (seroconversion rate during 1981-4 (2.5%)) and remained at 4.1% in 1989 (seroconversion rate nil during 1984-9). In contrast, positivity for anti-HBC rose from 44.0% in 1981 to 52.7% in 1984 (seroconversion rate 15.5%) and 58.8% in 1989 (seroconversion rate 12.9%), and that for anti-HIV rose from 8.8% to 24.0% (seroconversion rate 16.7%) and 30.1% (seroconversion rate 8.0%) respectively. Three anti-HCV positive patients seroreverted three to five years later. None of the anti-HCV positive subjects had had a transfusion and only one gave a past history of intravenous drug use. Variables in sexual lifestyle correlated with the presence of anti-HBc but not with that of anti-HCV. CONCLUSIONS--In contrast with hepatitis B virus and HIV, sexual transmission of hepatitis C virus seems to be a rare event. Furthermore, antibodies to the virus may become undetectable after several years. |
| doi_str_mv | 10.1136/bmj.301.6745.210 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1663579</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>29708581</jstor_id><sourcerecordid>29708581</sourcerecordid><originalsourceid>FETCH-LOGICAL-b641t-a010b132b820779eeaa6ad4fd098f643a2e38c5e4dd1e76d31879e298be2d0673</originalsourceid><addsrcrecordid>eNqFks9rFDEcxYModVl79yIEFFFk1nzzOz0IsrQqlFpQe5OQmcl0Z52ZrMlMaf97s-yyVS895fA-efm-7wtCz4EsAJh8X_brBSOwkIqLBQXyCM2AS10IzdhjNCNGmEID00_RcUprQghlShspjtARBdCc0Bn6-c3fTq7DY3RD6tuU2jDg0OCV37ixHduEl_imjVM6wVVYhTjiNE71HX4DRkNh3mLXh-Ean04xbLwb8Cr0Ie0sez88Q08a1yV_vD_n6MfZ6ffl5-L866cvy4_nRSk5jIUjQEpgtNSUKGW8d066mjc1MbqRnDnqma6E53UNXsmagc4UNbr0tCZSsTn6sPPdTGXv68oPOU9nN7HtXbyzwbX2X2VoV_Y63FiQkgllssHrvUEMvyefRpt3Ufmuc4MPU7LKGKXA8AdBEJpzZWgGX_4HrsMUh7wFC0rlUFQIlimyo6oYUoq-OcwMxG5Ltrlkm0u225JtLjlfefF31sOFfaVZf7XXXapc1-RiqzYdMK6AKyrubdZpDPHexSiiRf41c1Ts9DaN_vagu_grj8KUsBdXS3t5cWaMvryy22ff7fjtwA-G-APKiNTC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776432553</pqid></control><display><type>article</type><title>Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><source>Alma/SFX Local Collection</source><creator>Melbye, M ; Biggar, R J ; Wantzin, P ; Krogsgaard, K ; Ebbesen, P ; Becker, N G</creator><creatorcontrib>Melbye, M ; Biggar, R J ; Wantzin, P ; Krogsgaard, K ; Ebbesen, P ; Becker, N G</creatorcontrib><description>OBJECTIVE--To determine the prevalence, incidence, and persistence of positivity for antibodies to hepatitis C virus (anti-HCV) and the potential for sexual transmission of the virus. DESIGN--A cohort analysis covering 1981-9 comparing estimated cumulative incidences of and seroconversion rates for anti-HCV with those of hepatitis B core antibody (anti-HBc) and antibodies to the human immunodeficiency virus (anti-HIV). SETTING--Copenhagen and Aarhus, Denmark. SUBJECTS--259 Male members of a Danish homosexual organisation. MAIN OUTCOME MEASURES--Correlations of prevalence and incidence with a wide range of sexual lifestyle variables. RESULTS--Only four (1.6%) subjects were positive for anti-HCV in 1981. The estimated cumulative incidence of positivity for anti-HCV was 4.1% in 1984 (seroconversion rate during 1981-4 (2.5%)) and remained at 4.1% in 1989 (seroconversion rate nil during 1984-9). In contrast, positivity for anti-HBC rose from 44.0% in 1981 to 52.7% in 1984 (seroconversion rate 15.5%) and 58.8% in 1989 (seroconversion rate 12.9%), and that for anti-HIV rose from 8.8% to 24.0% (seroconversion rate 16.7%) and 30.1% (seroconversion rate 8.0%) respectively. Three anti-HCV positive patients seroreverted three to five years later. None of the anti-HCV positive subjects had had a transfusion and only one gave a past history of intravenous drug use. Variables in sexual lifestyle correlated with the presence of anti-HBc but not with that of anti-HCV. CONCLUSIONS--In contrast with hepatitis B virus and HIV, sexual transmission of hepatitis C virus seems to be a rare event. Furthermore, antibodies to the virus may become undetectable after several years.</description><identifier>ISSN: 0959-8138</identifier><identifier>ISSN: 0959-8146</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.301.6745.210</identifier><identifier>PMID: 2118402</identifier><language>eng</language><publisher>London: British Medical Journal Publishing Group</publisher><subject>Adult ; AIDS/HIV ; Antibodies ; Biological and medical sciences ; Blood transfusion ; Cohort Studies ; Denmark - epidemiology ; Hepacivirus ; Hepatitis ; Hepatitis Antibodies - analysis ; Hepatitis B ; Hepatitis B Antibodies - analysis ; Hepatitis B virus ; Hepatitis C ; Hepatitis C - epidemiology ; Hepatitis C - immunology ; Hepatitis C - transmission ; Hepatitis, Viral, Human - transmission ; HIV ; HIV Seropositivity - immunology ; Homosexuality ; Humans ; Infectious diseases ; Male ; Male homosexuality ; Medical sciences ; Middle Aged ; Sexual Partners ; Sexual transmission ; Sexually Transmitted Diseases, Viral - epidemiology ; Sexually Transmitted Diseases, Viral - immunology ; Time Factors ; Viruses</subject><ispartof>BMJ, 1990-07, Vol.301 (6745), p.210-212</ispartof><rights>Copyright 1990 British Medical Journal</rights><rights>1993 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Jul 28, 1990</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b641t-a010b132b820779eeaa6ad4fd098f643a2e38c5e4dd1e76d31879e298be2d0673</citedby><cites>FETCH-LOGICAL-b641t-a010b132b820779eeaa6ad4fd098f643a2e38c5e4dd1e76d31879e298be2d0673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/29708581$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/29708581$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,778,782,801,883,27911,27912,58004,58237</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4714725$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2118402$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Melbye, M</creatorcontrib><creatorcontrib>Biggar, R J</creatorcontrib><creatorcontrib>Wantzin, P</creatorcontrib><creatorcontrib>Krogsgaard, K</creatorcontrib><creatorcontrib>Ebbesen, P</creatorcontrib><creatorcontrib>Becker, N G</creatorcontrib><title>Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men</title><title>BMJ</title><addtitle>BMJ</addtitle><description>OBJECTIVE--To determine the prevalence, incidence, and persistence of positivity for antibodies to hepatitis C virus (anti-HCV) and the potential for sexual transmission of the virus. DESIGN--A cohort analysis covering 1981-9 comparing estimated cumulative incidences of and seroconversion rates for anti-HCV with those of hepatitis B core antibody (anti-HBc) and antibodies to the human immunodeficiency virus (anti-HIV). SETTING--Copenhagen and Aarhus, Denmark. SUBJECTS--259 Male members of a Danish homosexual organisation. MAIN OUTCOME MEASURES--Correlations of prevalence and incidence with a wide range of sexual lifestyle variables. RESULTS--Only four (1.6%) subjects were positive for anti-HCV in 1981. The estimated cumulative incidence of positivity for anti-HCV was 4.1% in 1984 (seroconversion rate during 1981-4 (2.5%)) and remained at 4.1% in 1989 (seroconversion rate nil during 1984-9). In contrast, positivity for anti-HBC rose from 44.0% in 1981 to 52.7% in 1984 (seroconversion rate 15.5%) and 58.8% in 1989 (seroconversion rate 12.9%), and that for anti-HIV rose from 8.8% to 24.0% (seroconversion rate 16.7%) and 30.1% (seroconversion rate 8.0%) respectively. Three anti-HCV positive patients seroreverted three to five years later. None of the anti-HCV positive subjects had had a transfusion and only one gave a past history of intravenous drug use. Variables in sexual lifestyle correlated with the presence of anti-HBc but not with that of anti-HCV. CONCLUSIONS--In contrast with hepatitis B virus and HIV, sexual transmission of hepatitis C virus seems to be a rare event. Furthermore, antibodies to the virus may become undetectable after several years.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Antibodies</subject><subject>Biological and medical sciences</subject><subject>Blood transfusion</subject><subject>Cohort Studies</subject><subject>Denmark - epidemiology</subject><subject>Hepacivirus</subject><subject>Hepatitis</subject><subject>Hepatitis Antibodies - analysis</subject><subject>Hepatitis B</subject><subject>Hepatitis B Antibodies - analysis</subject><subject>Hepatitis B virus</subject><subject>Hepatitis C</subject><subject>Hepatitis C - epidemiology</subject><subject>Hepatitis C - immunology</subject><subject>Hepatitis C - transmission</subject><subject>Hepatitis, Viral, Human - transmission</subject><subject>HIV</subject><subject>HIV Seropositivity - immunology</subject><subject>Homosexuality</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Male homosexuality</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Sexual Partners</subject><subject>Sexual transmission</subject><subject>Sexually Transmitted Diseases, Viral - epidemiology</subject><subject>Sexually Transmitted Diseases, Viral - immunology</subject><subject>Time Factors</subject><subject>Viruses</subject><issn>0959-8138</issn><issn>0959-8146</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFks9rFDEcxYModVl79yIEFFFk1nzzOz0IsrQqlFpQe5OQmcl0Z52ZrMlMaf97s-yyVS895fA-efm-7wtCz4EsAJh8X_brBSOwkIqLBQXyCM2AS10IzdhjNCNGmEID00_RcUprQghlShspjtARBdCc0Bn6-c3fTq7DY3RD6tuU2jDg0OCV37ixHduEl_imjVM6wVVYhTjiNE71HX4DRkNh3mLXh-Ean04xbLwb8Cr0Ie0sez88Q08a1yV_vD_n6MfZ6ffl5-L866cvy4_nRSk5jIUjQEpgtNSUKGW8d066mjc1MbqRnDnqma6E53UNXsmagc4UNbr0tCZSsTn6sPPdTGXv68oPOU9nN7HtXbyzwbX2X2VoV_Y63FiQkgllssHrvUEMvyefRpt3Ufmuc4MPU7LKGKXA8AdBEJpzZWgGX_4HrsMUh7wFC0rlUFQIlimyo6oYUoq-OcwMxG5Ltrlkm0u225JtLjlfefF31sOFfaVZf7XXXapc1-RiqzYdMK6AKyrubdZpDPHexSiiRf41c1Ts9DaN_vagu_grj8KUsBdXS3t5cWaMvryy22ff7fjtwA-G-APKiNTC</recordid><startdate>19900728</startdate><enddate>19900728</enddate><creator>Melbye, M</creator><creator>Biggar, R J</creator><creator>Wantzin, P</creator><creator>Krogsgaard, K</creator><creator>Ebbesen, P</creator><creator>Becker, N G</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19900728</creationdate><title>Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men</title><author>Melbye, M ; Biggar, R J ; Wantzin, P ; Krogsgaard, K ; Ebbesen, P ; Becker, N G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b641t-a010b132b820779eeaa6ad4fd098f643a2e38c5e4dd1e76d31879e298be2d0673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Antibodies</topic><topic>Biological and medical sciences</topic><topic>Blood transfusion</topic><topic>Cohort Studies</topic><topic>Denmark - epidemiology</topic><topic>Hepacivirus</topic><topic>Hepatitis</topic><topic>Hepatitis Antibodies - analysis</topic><topic>Hepatitis B</topic><topic>Hepatitis B Antibodies - analysis</topic><topic>Hepatitis B virus</topic><topic>Hepatitis C</topic><topic>Hepatitis C - epidemiology</topic><topic>Hepatitis C - immunology</topic><topic>Hepatitis C - transmission</topic><topic>Hepatitis, Viral, Human - transmission</topic><topic>HIV</topic><topic>HIV Seropositivity - immunology</topic><topic>Homosexuality</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Male homosexuality</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Sexual Partners</topic><topic>Sexual transmission</topic><topic>Sexually Transmitted Diseases, Viral - epidemiology</topic><topic>Sexually Transmitted Diseases, Viral - immunology</topic><topic>Time Factors</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Melbye, M</creatorcontrib><creatorcontrib>Biggar, R J</creatorcontrib><creatorcontrib>Wantzin, P</creatorcontrib><creatorcontrib>Krogsgaard, K</creatorcontrib><creatorcontrib>Ebbesen, P</creatorcontrib><creatorcontrib>Becker, N G</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Melbye, M</au><au>Biggar, R J</au><au>Wantzin, P</au><au>Krogsgaard, K</au><au>Ebbesen, P</au><au>Becker, N G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>1990-07-28</date><risdate>1990</risdate><volume>301</volume><issue>6745</issue><spage>210</spage><epage>212</epage><pages>210-212</pages><issn>0959-8138</issn><issn>0959-8146</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><abstract>OBJECTIVE--To determine the prevalence, incidence, and persistence of positivity for antibodies to hepatitis C virus (anti-HCV) and the potential for sexual transmission of the virus. DESIGN--A cohort analysis covering 1981-9 comparing estimated cumulative incidences of and seroconversion rates for anti-HCV with those of hepatitis B core antibody (anti-HBc) and antibodies to the human immunodeficiency virus (anti-HIV). SETTING--Copenhagen and Aarhus, Denmark. SUBJECTS--259 Male members of a Danish homosexual organisation. MAIN OUTCOME MEASURES--Correlations of prevalence and incidence with a wide range of sexual lifestyle variables. RESULTS--Only four (1.6%) subjects were positive for anti-HCV in 1981. The estimated cumulative incidence of positivity for anti-HCV was 4.1% in 1984 (seroconversion rate during 1981-4 (2.5%)) and remained at 4.1% in 1989 (seroconversion rate nil during 1984-9). In contrast, positivity for anti-HBC rose from 44.0% in 1981 to 52.7% in 1984 (seroconversion rate 15.5%) and 58.8% in 1989 (seroconversion rate 12.9%), and that for anti-HIV rose from 8.8% to 24.0% (seroconversion rate 16.7%) and 30.1% (seroconversion rate 8.0%) respectively. Three anti-HCV positive patients seroreverted three to five years later. None of the anti-HCV positive subjects had had a transfusion and only one gave a past history of intravenous drug use. Variables in sexual lifestyle correlated with the presence of anti-HBc but not with that of anti-HCV. CONCLUSIONS--In contrast with hepatitis B virus and HIV, sexual transmission of hepatitis C virus seems to be a rare event. Furthermore, antibodies to the virus may become undetectable after several years.</abstract><cop>London</cop><pub>British Medical Journal Publishing Group</pub><pmid>2118402</pmid><doi>10.1136/bmj.301.6745.210</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-8138 |
| ispartof | BMJ, 1990-07, Vol.301 (6745), p.210-212 |
| issn | 0959-8138 0959-8146 1468-5833 1756-1833 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1663579 |
| source | MEDLINE; Jstor Complete Legacy; Alma/SFX Local Collection |
| subjects | Adult AIDS/HIV Antibodies Biological and medical sciences Blood transfusion Cohort Studies Denmark - epidemiology Hepacivirus Hepatitis Hepatitis Antibodies - analysis Hepatitis B Hepatitis B Antibodies - analysis Hepatitis B virus Hepatitis C Hepatitis C - epidemiology Hepatitis C - immunology Hepatitis C - transmission Hepatitis, Viral, Human - transmission HIV HIV Seropositivity - immunology Homosexuality Humans Infectious diseases Male Male homosexuality Medical sciences Middle Aged Sexual Partners Sexual transmission Sexually Transmitted Diseases, Viral - epidemiology Sexually Transmitted Diseases, Viral - immunology Time Factors Viruses |
| title | Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T11%3A14%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sexual%20transmission%20of%20hepatitis%20C%20virus:%20cohort%20study%20(1981-9)%20among%20European%20homosexual%20men&rft.jtitle=BMJ&rft.au=Melbye,%20M&rft.date=1990-07-28&rft.volume=301&rft.issue=6745&rft.spage=210&rft.epage=212&rft.pages=210-212&rft.issn=0959-8138&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.301.6745.210&rft_dat=%3Cjstor_pubme%3E29708581%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776432553&rft_id=info:pmid/2118402&rft_jstor_id=29708581&rfr_iscdi=true |